"The FDA approval of Provenge leads to a huge spike for biotech firm."
http://www.forbes.com/2010/04/29/dendreon-provenge-fda-markets-equities-biotechnology.html?boxes=Homepagechannels
Also explains the halt in DNDN.
If VHL gets good phase II results from the VIR-201 trial it's gonna fly! Therapeutic vaccines just received an absolutely HUGE vote of confidence from the biggest player in the industry... the FDA.
I hope Virax management are following the story, and leverage via an investor roadshow or the like.
Victory smells close!
- Forums
- ASX - By Stock
- VHL
- dendreon hits the jackpot
dendreon hits the jackpot
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online